| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 9 |
| 1 | ADALIMUMAB | 7 |
| 2 | MYCOPHENOLATE MOFETIL | 7 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 7 |
| 4 | PREDNISOLONE | 7 |
| 5 | PREDNISOLONE ORAL | 7 |
| 6 | PREDNISOLONE ORAL SOLUTION | 7 |
| 7 | TACROLIMUS | 6 |
| 8 | GOLIMUMAB | 5 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 1 | AMILORIDE HYDROCHLORIDE | 1 | 0.0012 |
| 2 | NORGESTREL | 1 | 0.0007 |
| 3 | IVERMECTIN | 3 | 0.0007 |
| 4 | SATRALIZUMAB | 1 | 0.0006 |
| 5 | TOPOTECAN HYDROCHLORIDE | 1 | 0.0004 |
| 6 | GOLIMUMAB | 5 | 0.0004 |
| 7 | DEFLAZACORT | 1 | 0.0004 |
| 8 | INOTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 9 | LEVALBUTEROL HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 17 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 9 |
| 2 | Integrin Receptor Antagonist [EPC] | 6 |
| 3 | Anti-epileptic Agent [EPC] | 4 |
| 4 | Benzodiazepine [EPC] | 4 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 4 |
| 6 | Mood Stabilizer [EPC] | 4 |
| 7 | Provitamin D2 Compound [EPC] | 4 |
| 8 | Purine Antimetabolite [EPC] | 4 |
| 9 | Vitamin C [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Antiparasitic [EPC] | 3 | 0.0007 |
| 2 | Pediculicide [EPC] | 3 | 0.0006 |
| 3 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 6 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 7 | Integrin Receptor Antagonist [EPC] | 6 | 0.0001 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |